|
|
Post by madog365 on Jan 27, 2017 9:20:31 GMT -5
|
|
|
|
Post by mnholdem on Jan 27, 2017 9:23:41 GMT -5
I predict that MannKind management will start on time and that the Pro-Boards staff will have the Shout Box running.  |
|
|
|
Post by promann on Jan 27, 2017 9:27:40 GMT -5
I predict great news!! I also predict a sec reporting announcement 9:00 am Monday morning.   |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 27, 2017 9:27:59 GMT -5
Amgen, Google, Verily, Sanofi each bidding for 25% and some more.
and takeda and J&j for the rest
<sarcasm end>
obviously they must be getting bombarded with retail investors on falling script info and may have things to discuss since Mike is also in the call?
|
|
|
|
Post by madog365 on Jan 27, 2017 9:29:24 GMT -5
I predict that MannKind management will start on time and that the Pro-Boards staff will have the Shout Box running. Predicting the call will start on time is actually really bold. I would be willing to take the other side of that bet. As for my prediction. I will predict we see a global distribution partnership in one of the previously discussed countries. |
|
|
|
Post by mnkdnewb on Jan 27, 2017 9:34:01 GMT -5
Probably talk about how great things are going, just need a little time and it will be an epic turnaround. then might mention how a reverse split is a "great idea"
|
|
|
|
Post by Jstokcton on Jan 27, 2017 9:37:31 GMT -5
Partner for EPI-INHALER or reverse merger with RLS.
|
|
|
|
Post by kbrion77 on Jan 27, 2017 9:40:01 GMT -5
I'm sure this thread will run wild. Please tamper expectations. Conference Call will be about how Mannkind is ready to introduce Afrezza to the US their way and what they have currently put in place and putting in place throughout the year. Anyone expecting different will be disappointed.
|
|
|
|
Post by silentknight on Jan 27, 2017 9:40:48 GMT -5
Update on sales team roll out, perhaps a definitive date on NDA filing for Epi, followed by announcement of intent to R/S.
|
|
|
|
Post by lb on Jan 27, 2017 9:44:31 GMT -5
Amphastar partnership to launch in China.
|
|
|
|
Post by lsl428 on Jan 27, 2017 9:48:40 GMT -5
Update on sales team roll out, perhaps a definitive date on NDA filing for Epi, followed by announcement of intent to R/S. i tend to agree with above....RS is the news but will be tempered by some seemingly positive developments |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 27, 2017 9:50:09 GMT -5
I'm sure this thread will run wild. Please tamper expectations. Conference Call will be about how Mannkind is ready to introduce Afrezza to the US their way and what they have currently put in place and putting in place throughout the year. Anyone expecting different will be disappointed. this. |
|
|
|
Post by wildthing on Jan 27, 2017 9:58:19 GMT -5
Suspect they will announce they're seeking shareholder approval of a reverse split.
|
|
|
|
Post by promann on Jan 27, 2017 9:58:31 GMT -5
I also think a international partnership will be announced.. That's what we have been waiting for with selling abroad.. MNKD said in 3Q call that they have plans in several countries and they also have stated in previous calls they would not go at it alone and were searching for partner to market outside USA
|
|
|
|
Post by kc on Jan 27, 2017 9:58:58 GMT -5
Good news would always be Pre-Market. Bad news is after the market closes.
I wont get into the same long winded message that I have over the last 12 months. But the Board needs to put the company up for sale. We can't go it alone on a bootstrapped market plan. If you don't have the money to market and play the game you will ultimately fail. The board needs to find that buyer who has the capital to take it to the next level. The product is great but you can't sell something without a sales force and strong marketing/advertising.
Not sure what they are going to tell us on Wednesday but if it was good news it would occur pre-market and not at the market close.
|
|
